agilon health (AGL) to Release Quarterly Earnings on Tuesday

agilon health (NYSE:AGL) will likely be releasing its earnings data after the market closes on Tuesday, February 25th. Analysts expect agilon health to post earnings of ($0.18) per share and revenue of $1.52 billion for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

agilon health Trading Down 2.6 %

Shares of agilon health stock opened at $3.53 on Friday. The firm has a market capitalization of $1.45 billion, a PE ratio of -3.75 and a beta of 0.67. agilon health has a twelve month low of $1.50 and a twelve month high of $7.73. The firm’s 50-day moving average price is $2.82 and its 200 day moving average price is $3.08. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

Insider Activity

In other news, Director Karen Mcloughlin purchased 25,000 shares of agilon health stock in a transaction dated Friday, December 13th. The shares were purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the transaction, the director now owns 73,166 shares in the company, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Diana Mckenzie bought 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was bought at an average price of $2.28 per share, with a total value of $28,500.00. Following the acquisition, the director now directly owns 51,319 shares in the company, valued at $117,007.32. The trade was a 32.20 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 90,000 shares of company stock valued at $198,100. 3.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on AGL. Stifel Nicolaus decreased their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. Macquarie began coverage on shares of agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target on the stock. Needham & Company LLC began coverage on shares of agilon health in a research note on Friday, January 10th. They issued a “hold” rating on the stock. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Finally, William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $4.03.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.